AUROBINDO PHARMA
|
AUROBINDO PHARMA Last 5 Year Income Statement History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
INCOME : | |||||
Gross Sales | ₹63,559 Cr | ₹59,784 Cr | ₹50,860 Cr | ₹47,812 Cr | ₹48,590 Cr |
Sales | ₹62,845 Cr | ₹59,006 Cr | ₹50,109 Cr | ₹47,481 Cr | ₹48,238 Cr |
Job Work/ Contract Receipts | - | - | - | - | - |
Processing Charges / Service Income | ₹368 Cr | ₹481 Cr | ₹513 Cr | ₹242 Cr | ₹135 Cr |
Revenue from property development | - | - | - | - | - |
Other Operational Income | ₹346 Cr | ₹297 Cr | ₹238 Cr | ₹89 Cr | ₹217 Cr |
Less: Excise Duty | - | - | - | - | - |
Net Sales | ₹31,724 Cr | ₹29,002 Cr | ₹24,855 Cr | ₹23,455 Cr | ₹24,775 Cr |
EXPENDITURE : | |||||
Increase/Decrease in Stock | ₹-598 Cr | ₹-946 Cr | ₹-410 Cr | ₹817 Cr | ₹-730 Cr |
Raw Material Consumed | ₹12,270 Cr | ₹12,295 Cr | ₹10,600 Cr | ₹8,422 Cr | ₹9,558 Cr |
Opening Raw Materials | ₹2,920 Cr | ₹2,681 Cr | ₹2,378 Cr | ₹3,028 Cr | ₹2,434 Cr |
Purchases Raw Materials | ₹9,360 Cr | ₹9,762 Cr | ₹8,853 Cr | ₹5,817 Cr | ₹7,836 Cr |
Closing Raw Materials | ₹2,904 Cr | ₹2,920 Cr | ₹2,681 Cr | ₹2,374 Cr | ₹3,028 Cr |
Other Direct Purchases / Brought in cost | ₹2,887 Cr | ₹2,773 Cr | ₹2,050 Cr | ₹1,952 Cr | ₹2,315 Cr |
Other raw material cost | ₹6.36 Cr | ₹-1.24 Cr | - | - | - |
Power & Fuel Cost | ₹1,012 Cr | ₹826 Cr | ₹843 Cr | ₹627 Cr | ₹589 Cr |
Electricity & Power | ₹1,012 Cr | ₹826 Cr | ₹843 Cr | ₹627 Cr | ₹589 Cr |
Oil, Fuel & Natural gas | - | - | - | - | - |
Coals etc | - | - | - | - | - |
Other power & fuel | - | - | - | - | - |
Employee Cost | ₹4,476 Cr | ₹3,923 Cr | ₹3,522 Cr | ₹3,451 Cr | ₹3,535 Cr |
Salaries, Wages & Bonus | ₹3,925 Cr | ₹3,413 Cr | ₹3,073 Cr | ₹3,021 Cr | ₹3,070 Cr |
Contributions to EPF & Pension Funds | ₹260 Cr | ₹228 Cr | ₹159 Cr | ₹150 Cr | ₹144 Cr |
Workmen and Staff Welfare Expenses | ₹173 Cr | ₹184 Cr | ₹228 Cr | ₹213 Cr | ₹244 Cr |
Other Employees Cost | ₹116 Cr | ₹97 Cr | ₹62 Cr | ₹66 Cr | ₹78 Cr |
Other Manufacturing Expenses | ₹3,556 Cr | ₹3,192 Cr | ₹2,810 Cr | ₹2,503 Cr | ₹2,875 Cr |
Sub-contracted / Out sourced services | - | - | - | - | - |
Processing Charges | ₹69 Cr | ₹80 Cr | ₹36 Cr | ₹27 Cr | ₹65 Cr |
Repairs and Maintenance | ₹518 Cr | ₹429 Cr | ₹384 Cr | ₹357 Cr | ₹336 Cr |
Packing Material Consumed | ₹1,354 Cr | ₹1,254 Cr | ₹1,103 Cr | ₹901 Cr | ₹1,075 Cr |
Other Mfg Exp | ₹1,616 Cr | ₹1,428 Cr | ₹1,287 Cr | ₹1,218 Cr | ₹1,400 Cr |
General and Administration Expenses | ₹1,552 Cr | ₹1,484 Cr | ₹1,387 Cr | ₹1,335 Cr | ₹1,474 Cr |
Rent , Rates & Taxes | ₹166 Cr | ₹204 Cr | ₹242 Cr | ₹227 Cr | ₹212 Cr |
Insurance | ₹138 Cr | ₹131 Cr | ₹121 Cr | ₹113 Cr | ₹89 Cr |
Printing and stationery | ₹41 Cr | ₹36 Cr | ₹32 Cr | ₹32 Cr | ₹34 Cr |
Professional and legal fees | ₹1,050 Cr | ₹979 Cr | ₹875 Cr | ₹872 Cr | ₹1,049 Cr |
Traveling and conveyance | ₹117 Cr | ₹99 Cr | ₹82 Cr | ₹53 Cr | ₹47 Cr |
Other Administration | ₹39 Cr | ₹36 Cr | ₹34 Cr | ₹38 Cr | ₹42 Cr |
Selling and Distribution Expenses | ₹2,185 Cr | ₹1,685 Cr | ₹1,686 Cr | ₹1,497 Cr | ₹1,564 Cr |
Advertisement & Sales Promotion | - | - | - | - | - |
Sales Commissions & Incentives | ₹182 Cr | ₹155 Cr | ₹134 Cr | ₹280 Cr | ₹245 Cr |
Freight and Forwarding | ₹1,136 Cr | ₹950 Cr | ₹1,087 Cr | ₹773 Cr | ₹838 Cr |
Handling and Clearing Charges | - | - | - | - | - |
Other Selling Expenses | ₹867 Cr | ₹580 Cr | ₹465 Cr | ₹444 Cr | ₹481 Cr |
Miscellaneous Expenses | ₹688 Cr | ₹701 Cr | ₹699 Cr | ₹420 Cr | ₹576 Cr |
Bad debts /advances written off | ₹13 Cr | ₹7.00 Cr | - | - | - |
Provision for doubtful debts | ₹5.39 Cr | ₹17 Cr | ₹52 Cr | - | ₹28 Cr |
Losson disposal of fixed assets(net) | ₹8.94 Cr | ₹51 Cr | - | ₹40 Cr | ₹141 Cr |
Losson foreign exchange fluctuations | ₹23 Cr | - | ₹40 Cr | - | - |
Losson sale of non-trade current investments | - | - | - | - | - |
Other Miscellaneous Expenses | ₹638 Cr | ₹626 Cr | ₹607 Cr | ₹380 Cr | ₹407 Cr |
Less: Expenses Capitalised | - | - | - | - | - |
Total Expenditure | ₹25,141 Cr | ₹23,159 Cr | ₹21,137 Cr | ₹19,071 Cr | ₹19,441 Cr |
Operating Profit (Excl OI) | ₹6,583 Cr | ₹5,843 Cr | ₹3,719 Cr | ₹4,385 Cr | ₹5,333 Cr |
Other Income | ₹622 Cr | ₹557 Cr | ₹291 Cr | ₹323 Cr | ₹381 Cr |
Interest Received | ₹353 Cr | ₹286 Cr | ₹146 Cr | ₹32 Cr | ₹17 Cr |
Dividend Received | ₹3.17 Cr | ₹2.54 Cr | ₹2.63 Cr | ₹3.37 Cr | - |
Profit on sale of Fixed Assets | - | ₹23 Cr | ₹13 Cr | - | - |
Profits on sale of Investments | ₹34 Cr | ₹0.10 Cr | - | ₹29 Cr | - |
Provision Written Back | ₹12 Cr | ₹10 Cr | ₹13 Cr | ₹68 Cr | ₹83 Cr |
Foreign Exchange Gains | - | ₹39 Cr | - | ₹70 Cr | ₹104 Cr |
Others | ₹220 Cr | ₹197 Cr | ₹116 Cr | ₹121 Cr | ₹178 Cr |
Operating Profit | ₹7,205 Cr | ₹6,400 Cr | ₹4,009 Cr | ₹4,707 Cr | ₹5,714 Cr |
Interest | ₹457 Cr | ₹290 Cr | ₹140 Cr | ₹49 Cr | ₹74 Cr |
InterestonDebenture / Bonds | - | - | - | - | - |
Interest on Term Loan | - | - | - | - | - |
Intereston Fixed deposits | - | - | - | - | - |
Bank Charges etc | ₹17 Cr | ₹22 Cr | ₹12 Cr | ₹12 Cr | ₹15 Cr |
Other Interest | ₹440 Cr | ₹268 Cr | ₹129 Cr | ₹37 Cr | ₹60 Cr |
PBDT | ₹6,747 Cr | ₹6,111 Cr | ₹3,869 Cr | ₹4,658 Cr | ₹5,640 Cr |
Depreciation | ₹1,649 Cr | ₹1,522 Cr | ₹1,245 Cr | ₹1,127 Cr | ₹1,055 Cr |
Profit Before Taxation & Exceptional Items | ₹5,098 Cr | ₹4,589 Cr | ₹2,624 Cr | ₹3,532 Cr | ₹4,584 Cr |
Exceptional Income / Expenses | - | ₹-192 Cr | - | ₹-128 Cr | ₹2,815 Cr |
Profit Before Tax | ₹5,066 Cr | ₹4,380 Cr | ₹2,613 Cr | ₹3,373 Cr | ₹7,344 Cr |
Provision for Tax | ₹1,583 Cr | ₹1,211 Cr | ₹685 Cr | ₹726 Cr | ₹2,010 Cr |
Current Income Tax | ₹1,700 Cr | ₹1,778 Cr | ₹1,071 Cr | ₹663 Cr | ₹2,322 Cr |
Deferred Tax | ₹-117 Cr | ₹-567 Cr | ₹-387 Cr | ₹63 Cr | ₹-312 Cr |
Other taxes | - | - | - | - | - |
Profit After Tax | ₹3,484 Cr | ₹3,169 Cr | ₹1,928 Cr | ₹2,647 Cr | ₹5,334 Cr |
Extra items | - | - | - | - | - |
Minority Interest | ₹2.31 Cr | ₹4.00 Cr | ₹-0.15 Cr | ₹1.04 Cr | ₹1.02 Cr |
Share of Associate | - | - | - | - | - |
Other Consolidated Items | - | - | - | - | - |
Consolidated Net Profit | ₹3,486 Cr | ₹3,173 Cr | ₹1,928 Cr | ₹2,648 Cr | ₹5,335 Cr |
Adjustments to PAT | - | - | - | - | - |
Profit Balance B/F | ₹26,801 Cr | ₹23,910 Cr | ₹22,519 Cr | ₹20,137 Cr | ₹15,042 Cr |
Appropriations | ₹30,287 Cr | ₹27,083 Cr | ₹24,446 Cr | ₹22,785 Cr | ₹20,377 Cr |
General Reserves | - | - | - | - | - |
Proposed Equity Dividend | - | - | - | - | - |
Corporate dividend tax | - | - | - | - | - |
Other Appropriation | ₹-198 Cr | ₹282 Cr | ₹360 Cr | ₹2.25 Cr | ₹6.10 Cr |
Equity Dividend % | - | ₹450.00 | ₹300.00 | ₹900.00 | ₹400.00 |
Earnings Per Share | ₹60.02 | ₹54.16 | ₹32.90 | ₹45.20 | ₹91.05 |
Adjusted EPS | ₹60.02 | ₹54.16 | ₹32.90 | ₹45.20 | ₹91.05 |
Compare Income Statement of peers of AUROBINDO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AUROBINDO PHARMA | ₹60,658.8 Cr | 1.8% | -3.3% | -33.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹382,622.0 Cr | 2% | -2.3% | -12.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,536.0 Cr | -1.3% | -6.2% | 21.2% | Stock Analytics | |
CIPLA | ₹125,468.0 Cr | -2.2% | 3.6% | -4.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,162.0 Cr | -0% | -0.3% | 5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,874.0 Cr | -0.9% | 4.5% | -8.6% | Stock Analytics |
AUROBINDO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AUROBINDO PHARMA | 1.8% |
-3.3% |
-33.2% |
SENSEX | 1.1% |
-0.4% |
-2.2% |
You may also like the below Video Courses